Can I prescribe Paxlovid (nirmatrelvir + ritonavir) together with Xofluza (baloxavir marboxil)?

Can You Prescribe Paxlovid and Xofluza Together?

Yes, you can prescribe Paxlovid (nirmatrelvir/ritonavir) and Xofluza (baloxavir marboxil) together—there is no documented drug-drug interaction between these two antivirals, as they treat different viral infections (COVID-19 and influenza, respectively) and have distinct mechanisms of action and metabolic pathways.

Key Considerations

Why This Combination is Safe

The primary concern with Paxlovid is the ritonavir component, which is a potent CYP3A4 inhibitor that causes numerous drug-drug interactions 12. However, baloxavir marboxil (Xofluza) is not significantly metabolized through CYP3A4 pathways. The main interaction concern with Xofluza is with polyvalent cations (calcium, aluminum, magnesium products), which reduce its antiviral efficacy 3.

Critical Drug Interaction Screening Required

While Paxlovid and Xofluza can be co-prescribed, you must still conduct a comprehensive drug interaction review before prescribing Paxlovid, as the FDA label carries a black box warning about significant drug interactions 1. The ritonavir component:

• Inhibits CYP3A4 potently and rapidly
• Can lead to severe, life-threatening, or fatal events with certain concomitant medications
• Requires assessment of ALL medications the patient is taking 12

Practical Prescribing Algorithm

When considering this combination:

1. Confirm appropriate indications:

   • Paxlovid: Mild-to-moderate COVID-19 in high-risk patients within 5 days of symptom onset 45
   • Xofluza: Influenza treatment or prevention

2. Screen for Paxlovid contraindications:

   • Review all medications using interaction checkers (Liverpool COVID-19 drug interaction tool recommended) 52
   • Check renal function (dose adjust if eGFR 30-59 mL/min; avoid if <30 mL/min) 11
   • Assess hepatic function (avoid in Child-Pugh Class C) 1

3. Counsel patient on Xofluza-specific interactions:

   • Avoid calcium, aluminum, or magnesium products during Xofluza treatment 3

4. Initiate both medications as indicated if no contraindications exist

Common Pitfalls to Avoid

• Don't assume Paxlovid is safe just because Xofluza is compatible. Among commonly prescribed medications, 30% have potential interactions with Paxlovid, and 14% require careful evaluation 6. In polymedicated patients, 87.1% required pharmacist interventions to prevent drug-related problems 7.

• Don't forget renal dosing. In patients with moderate renal impairment (eGFR 30-59 mL/min), reduce Paxlovid to 150 mg nirmatrelvir with 100 mg ritonavir twice daily 11.

• Don't overlook the 5-day treatment window. Both medications work best when initiated early—Paxlovid within 5 days of COVID-19 symptom onset 55.

Evidence Quality Note

The evidence supporting Paxlovid's efficacy is robust, with high certainty for reducing hospitalizations and moderate certainty for mortality benefit in high-risk patients 55. Real-world data confirms effectiveness even in vaccinated patients during the Omicron era 8. However, no specific studies have evaluated the Paxlovid-Xofluza combination, as this would represent co-infection or sequential infection scenarios that are uncommon and not typically studied in clinical trials.